St. Jude Medical (STJ +0.2%) says data from its catheter study, presented today at the annual...

|About: St. Jude Medical, Inc. (STJ)|By:, SA News Editor

St. Jude Medical (STJ +0.2%) says data from its catheter study, presented today at the annual scientific meeting of the American Heart Association, showed that it’s EnligHTN renal denervation system provided a significant reduction in office and ambulatory blood pressure measurements at six months. In addition, those treated with the system began experiencing a reduction in blood pressure reduction after just 30 days.